# Seer

**Canonical:** https://apis.io/providers/seer/  
**Website:** https://seer.bio/  
**APIs profiled:** 0

Seer, Inc. (NASDAQ: SEER) is a Redwood City, California life-sciences company pioneering proteomics, the large-scale study of proteins. Its Proteograph Product Suite pairs engineered nanoparticles with automated sample preparation and mass spectrometry to profile tens of thousands of proteins across biological samples at scale, and its cloud-based Proteograph Analysis System (PAS) software processes and interprets the resulting proteomic data for pharmaceutical, biopharma, and academic research. Seer exposes no public developer API; its software surface is the login-gated PAS platform delivered to customers of the Proteograph suite.

## Kin Score — 14.1 / 100 (emerging)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 14.1).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 19.0 |
| Commercial Clarity | 27.6 |
| Access Clarity | 27.6 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Seer Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Health Tech, Proteomics, Life Sciences, Biotechnology, Mass Spectrometry, Research Tools

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/seer/). Scores are computed from the provider's own public artifacts under a published rubric.